Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial

Table 3

The multivariable linear regression analysis for assessing predictors of NIHSS.

Variable			95% CI	value
Group	Placebo group	Reference
	ALC group	-2.40	-0.69, -4.10	0.007
Age, years		0.06	-0.003, 0.13	0.06
Diabetes	No	Reference
	Yes	1.68	-0.14, 3.49	0.07
NIHSS before		0.49	0.29, 0.69	<0.001

Note: ALC = acetyl-L-carnitine. Adjusted for other variables in the model. The significant value is shown in bold type.